Use of Toll-like Receptor Agonist for Treating Cancer
10 Jun 21
The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin.
Anatoli GLEIBERMAN, Lyudmila BURDELYA, Andrei GUDKOV
Filed: 21 Jul 20
